Page 2 - Nasdaq Tern News Today

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) – Equities researchers at HC Wainwright cut their FY2023 earnings estimates for shares of Terns Pharmaceuticals in a research note issued to investors on Thursday, November 16th. HC Wainwright analyst E. Arce now anticipates that the company will post earnings per share of ($1.27) for the year, down […]

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has been given an average rating of “Moderate Buy” by the nine ratings firms that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price […]

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has received an average recommendation of “Moderate Buy” from the nine analysts that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month price objective […]

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the nine analysts that are presently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average twelve-month target price among […]

Terns Pharmaceuticals (NASDAQ:TERN – Free Report) had its price objective lifted by JPMorgan Chase & Co. from $10.00 to $11.00 in a report published on Wednesday morning, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock. Other research analysts have also recently issued research reports about the stock. Roth Mkm […]

Terns Pharmaceuticals (NASDAQ:TERN – Free Report) had its price target upped by Mizuho from $16.00 to $17.00 in a research note issued to investors on Wednesday, FlyOnTheWall reports. Several other research firms have also recently issued reports on TERN. Roth Mkm reissued a buy rating and set a $23.00 target price on shares of Terns […]

Terns Pharmaceuticals (NASDAQ:TERN – Free Report) had its target price trimmed by HC Wainwright from $11.00 to $8.00 in a report issued on Wednesday morning, MarketBeat Ratings reports. The brokerage currently has a neutral rating on the stock. HC Wainwright also issued estimates for Terns Pharmaceuticals’ Q3 2023 earnings at ($0.33) EPS, Q4 2023 earnings […]

Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report) had its target price reduced by equities researchers at HC Wainwright from $11.00 to $8.00 in a report issued on Wednesday, FlyOnTheWall reports. HC Wainwright’s target price would suggest a potential upside of 24.42% from the company’s previous close. TERN has been the subject of a number of […]

Senthil Sundaram Stepping Down as Chief Executive Officer for Health Reasons...

Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) have been given a consensus rating of “Moderate Buy” by the nine research firms that are presently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. […]